Format

Send to

Choose Destination
Tumori. 2014 May-Jun;100(3):e83-6. doi: 10.1700/1578.17240.

Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report.

Abstract

AIMS AND BACKGROUND:

In recent years, targeted agents have replaced cytokine therapy as the standard of care for patients with metastatic renal cell carcinoma.

METHODS AND STUDY DESIGN:

We report a patient with multiple metastases from renal cell carcinoma treated with cytoreductive surgery and pazopanib.

RESULTS AND CONCLUSIONS:

The treatment resulted in an early and prolonged response, without toxicity.

PMID:
25076257
DOI:
10.1700/1578.17240
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center